Computational Modeling of Interactions between Multiple Myeloma and the Bone Microenvironment
Open Access
- 8 November 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (11), e27494
- https://doi.org/10.1371/journal.pone.0027494
Abstract
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It has been postulated that positive feedback loops in the interactions between MM cells and the bone microenvironment form reinforcing ‘vicious cycles’, resulting in more bone resorption and MM cell population growth in the bone microenvironment. Despite many identified MM-bone interactions, the combined effect of these interactions and their relative importance are unknown. In this paper, we develop a computational model of MM-bone interactions and clarify whether the intercellular signaling mechanisms implemented in this model appropriately drive MM disease progression. This new computational model is based on the previous bone remodeling model of Pivonka et al. [1], and explicitly considers IL-6 and MM-BMSC (bone marrow stromal cell) adhesion related pathways, leading to formation of two positive feedback cycles in this model. The progression of MM disease is simulated numerically, from normal bone physiology to a well established MM disease state. Our simulations are consistent with known behaviors and data reported for both normal bone physiology and for MM disease. The model results suggest that the two positive feedback cycles identified for this model are sufficient to jointly drive the MM disease progression. Furthermore, quantitative analysis performed on the two positive feedback cycles clarifies the relative importance of the two positive feedback cycles, and identifies the dominant processes that govern the behavior of the two positive feedback cycles. Using our proposed quantitative criteria, we identify which of the positive feedback cycles in this model may be considered to be ‘vicious cycles’. Finally, key points at which to block the positive feedback cycles in MM-bone interactions are identified, suggesting potential drug targets.Keywords
This publication has 91 references indexed in Scilit:
- A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone diseaseBiology Direct, 2010
- Dynamics of multiple myeloma tumor therapy with a recombinant measles virusCancer Gene Therapy, 2009
- The role of Dickkopf-1 in bone development, homeostasis, and diseaseBlood, 2009
- The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivoAmerican Journal of Hematology, 2008
- Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growthBlood, 2008
- The pathogenesis of the bone disease of multiple myelomaBone, 2008
- A cytokine-mediated link between innate immunity, inflammation, and cancerJournal of Clinical Investigation, 2007
- Statistical Epistasis Is a Generic Feature of Gene Regulatory NetworksGenetics, 2007
- Myeloma bone disease and treatment optionsEuropean Journal Of Cancer, 2006
- Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone diseaseBiochemical and Biophysical Research Communications, 2005